IO Biotech, Inc. (IOBTQ) Depreciation & Amortization (CF) (2022 - 2025)

IO Biotech (IOBTQ) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $100000.0 in Q3 2025.

• Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $100000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $400000.0 (up 33.33% YoY) and the FY2024 annual result came in at $300000.0, up 50.0% from the prior year.
• Depreciation & Amortization (CF) held at $100000.0 in Q3 2025, from $100000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2023 to a low of $10000.0 in Q3 2022.
• A 4-year average of $85833.3 and a median of $100000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 900.0% — and 2024, when it changed 0.0%.
• Tracing IOBTQ's Depreciation & Amortization (CF) over 4 years: stood at $70000.0 in 2022, then jumped by 42.86% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $100000.0 (Q3 2025), $100000.0 (Q2 2025), and $100000.0 (Q1 2025), per Business Quant data.